ALDH1L1 and hepatocellular carcinoma: Recent clinical studies indicated that ALDH1L1 expression is a candidate prognostic biomarker of hepatitis B virus-related HCC patients (i.e., patients with lower expression of ALDH1L1 show shorter survival)16.